Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease

Annals of Thoracic Surgery

Volumn 70, Issue 4, 2000, Pages 1308-1312

  Chauhan, Sandeep ^a   Kumar, Bisoi Akshay ^a   Rao, Beeraka Heramba ^a   Rao, Marigaddi Sanjeeva ^a   Dubey, Bharat ^a   Saxena, Nita ^a   Venugopal, Panangipalli ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; FIBRINOGEN; THROMBOCYTE CONCENTRATE;

ADOLESCENT; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DRUG EFFICACY; DRUG MECHANISM; ERYTHROCYTE CONCENTRATE; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; STERNUM;

6-AMINOCAPROIC ACID; ADOLESCENT; ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HEART DEFECTS, CONGENITAL; HUMAN; INFANT; MALE; PROSPECTIVE STUDIES;

EID: 0033787561     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01752-5     Document Type: Article

References (14)

1. Treatment of excessive mediastinal bleeding after cardiopulmonary bypass
2. Coagulation defects in neonates undergoing cardiopulmonary bypass
3. Mediastinal bleeding after cardiopulmonary bypass in pediatric patients
4. Natural and synthetic antifibrinolytics in adult cardiac surgery: Efficacy, effectiveness and efficiency
5. Aprotinin and cardiac surgery: Reduces blood loss
6. Aprotinin in children undergoing correction of congenital heart defects: A double blind pilot study
7. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass
8. The role of epsilon aminocaproic acid in reducing bleeding after cardiac operation: A double blind randomised study
9. Prophylactic E aminocaproic acid (EACA) administration minimises blood replacement therapy during cardiac surgery
10. ε-Aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart disease
11. The use of epsilon aminocaproic acid to reduce bleeding during cardiac bypass in children with congenital heart disease
12. Studies on the cause of bleeding during and after surgery with a heart lung machine in children with cyanotic and acyanotic congenital cardiac defects and their prophylactic treatment
13. Prospective randomised double blind study of high dose aprotinin in pediatric cardiac operations
14. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss